Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Theresa Grover

Concepts (345)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Intensive Care Units, Neonatal
36
2026
280
4.080
Why?
Hernias, Diaphragmatic, Congenital
18
2026
219
4.000
Why?
Extracorporeal Membrane Oxygenation
9
2026
367
1.730
Why?
Infant, Newborn
61
2026
6418
1.610
Why?
Infant, Premature
14
2025
612
1.530
Why?
Catheterization, Central Venous
6
2025
120
1.360
Why?
Cross Infection
3
2025
263
1.310
Why?
Bacterial Infections
2
2025
246
1.250
Why?
Bronchopulmonary Dysplasia
10
2024
407
1.100
Why?
Central Venous Catheters
5
2025
53
1.040
Why?
Urinary Tract Infections
4
2025
203
1.030
Why?
Pulmonary Circulation
15
2011
429
0.910
Why?
Gestational Age
17
2025
978
0.910
Why?
Length of Stay
12
2026
1317
0.890
Why?
Enteral Nutrition
4
2025
214
0.860
Why?
Mycoses
1
2025
88
0.860
Why?
Catheter-Related Infections
4
2017
92
0.760
Why?
Gastroschisis
4
2025
32
0.710
Why?
Quality Improvement
9
2024
1275
0.600
Why?
Catheterization, Peripheral
1
2021
117
0.600
Why?
Hypertension, Pulmonary
11
2021
1981
0.600
Why?
Bottle Feeding
1
2019
20
0.600
Why?
Fetus
14
2020
807
0.580
Why?
Infant
27
2026
10095
0.570
Why?
Retrospective Studies
33
2026
16942
0.570
Why?
Infant Formula
1
2019
75
0.570
Why?
Hospitals, Pediatric
6
2025
557
0.560
Why?
Vascular Endothelial Growth Factor A
6
2007
562
0.550
Why?
Bacteremia
4
2024
219
0.540
Why?
Practice Guidelines as Topic
6
2024
1566
0.530
Why?
Postoperative Complications
5
2025
2938
0.520
Why?
Lung
10
2011
4130
0.520
Why?
Parenteral Nutrition, Total
1
2017
30
0.520
Why?
Vasodilation
11
2011
518
0.490
Why?
Weight Gain
2
2017
553
0.480
Why?
Sheep
20
2011
886
0.480
Why?
Intensive Care, Neonatal
4
2020
40
0.460
Why?
High-Frequency Ventilation
1
2015
45
0.450
Why?
Infant, Premature, Diseases
2
2024
108
0.440
Why?
Intersectoral Collaboration
1
2015
60
0.440
Why?
Developmental Disabilities
1
2018
294
0.430
Why?
Patient Education as Topic
1
2019
786
0.410
Why?
Nitric Oxide Synthase
9
2006
241
0.400
Why?
Tracheostomy
3
2024
145
0.390
Why?
Humans
64
2026
144746
0.380
Why?
Endothelial Growth Factors
2
2002
64
0.380
Why?
Lymphokines
2
2002
131
0.370
Why?
Anti-Bacterial Agents
4
2024
1916
0.370
Why?
Female
54
2026
78073
0.370
Why?
Hospitalization
3
2021
2342
0.370
Why?
Patient Discharge
6
2025
933
0.350
Why?
Nitric Oxide
10
2011
900
0.350
Why?
Surgical Procedures, Operative
1
2014
274
0.340
Why?
Intercellular Signaling Peptides and Proteins
2
2002
388
0.330
Why?
Pulmonary Artery
11
2011
1124
0.320
Why?
Intubation, Intratracheal
2
2024
314
0.320
Why?
Parents
1
2019
1468
0.310
Why?
Respiration, Artificial
6
2026
711
0.300
Why?
Male
33
2026
72210
0.300
Why?
Databases, Factual
7
2025
1478
0.300
Why?
Hospital Mortality
4
2026
966
0.300
Why?
Persistent Fetal Circulation Syndrome
2
2011
138
0.290
Why?
Anesthesia
2
2023
251
0.290
Why?
Survival Rate
4
2018
2025
0.280
Why?
Pregnancy
23
2021
7211
0.280
Why?
Patient Care Bundles
2
2019
28
0.270
Why?
Lung Diseases
1
2014
791
0.260
Why?
Infant Mortality
2
2026
123
0.250
Why?
Nitric Oxide Synthase Type III
6
2007
201
0.250
Why?
Guideline Adherence
4
2025
576
0.250
Why?
Fibrin
1
2007
91
0.240
Why?
Fetal Diseases
3
2004
191
0.240
Why?
Urea Cycle Disorders, Inborn
1
2026
25
0.240
Why?
Intestinal Atresia
1
2025
17
0.240
Why?
Hernia, Diaphragmatic
1
2026
67
0.240
Why?
Jejunum
1
2025
34
0.230
Why?
Hospitals, High-Volume
1
2026
48
0.230
Why?
Guanylate Cyclase
4
2011
38
0.230
Why?
Multivariate Analysis
5
2025
1514
0.230
Why?
Heart Defects, Congenital
2
2026
899
0.230
Why?
Logistic Models
6
2025
2111
0.230
Why?
Pulmonary Alveoli
2
2005
393
0.230
Why?
Infection Control
2
2017
174
0.220
Why?
Bradycardia
2
2024
59
0.220
Why?
Ileum
1
2025
113
0.220
Why?
Hypoxia-Inducible Factor 1, alpha Subunit
1
2007
303
0.220
Why?
Anastomotic Leak
1
2024
46
0.210
Why?
Ventilator Weaning
1
2024
39
0.210
Why?
Ductus Arteriosus, Patent
1
2025
53
0.210
Why?
Consensus
2
2024
494
0.210
Why?
Esophageal Atresia
1
2024
30
0.210
Why?
Device Removal
1
2025
145
0.210
Why?
North America
1
2025
312
0.210
Why?
Stenosis, Pulmonary Vein
1
2024
19
0.210
Why?
Tracheoesophageal Fistula
1
2024
37
0.210
Why?
Blood Culture
1
2024
24
0.210
Why?
Critical Pathways
1
2025
108
0.210
Why?
Cyclic GMP
4
2011
91
0.210
Why?
Clinical Protocols
1
2025
283
0.200
Why?
Severity of Illness Index
6
2026
2953
0.200
Why?
Laryngoscopy
1
2024
123
0.190
Why?
Ductus Arteriosus
6
2008
73
0.190
Why?
Neovascularization, Pathologic
1
2004
295
0.190
Why?
Delphi Technique
1
2024
328
0.180
Why?
Hemangioendothelioma
1
2002
13
0.180
Why?
Infant, Newborn, Diseases
1
2023
113
0.180
Why?
Infant, Small for Gestational Age
2
2025
109
0.170
Why?
Time Factors
7
2024
7074
0.170
Why?
Uterus
1
2002
227
0.170
Why?
Patient Handoff
1
2021
42
0.170
Why?
Retrognathia
1
2020
5
0.170
Why?
Hepatitis B Vaccines
1
2021
48
0.170
Why?
Animals, Newborn
7
2009
882
0.170
Why?
Micrognathism
1
2020
19
0.160
Why?
Neuromuscular Blockade
1
2021
50
0.160
Why?
Hepatitis B
1
2021
71
0.160
Why?
Social Determinants of Health
1
2024
294
0.160
Why?
Betamethasone
1
2000
21
0.160
Why?
Benzoates
2
2011
49
0.160
Why?
Analgesia
1
2021
105
0.160
Why?
Vascular Resistance
6
2011
365
0.160
Why?
Ventricular Septum
1
2019
8
0.160
Why?
Carbon Monoxide
1
2000
83
0.150
Why?
Hypothermia
1
2020
49
0.150
Why?
Incidence
2
2018
2864
0.150
Why?
United States
7
2025
15694
0.150
Why?
Cooperative Behavior
3
2017
459
0.150
Why?
Food, Fortified
1
2019
43
0.150
Why?
Geographic Mapping
1
2019
27
0.150
Why?
Blood Pressure
5
2019
1767
0.140
Why?
Neonatology
1
2019
33
0.140
Why?
Airway Obstruction
1
2020
168
0.140
Why?
Receptors, Cytoplasmic and Nuclear
2
2011
209
0.140
Why?
Endothelium, Vascular
1
2005
965
0.140
Why?
Recombinant Proteins
4
2005
1372
0.140
Why?
Animals
22
2011
38223
0.140
Why?
Community-Acquired Infections
1
2020
180
0.140
Why?
Respiratory Insufficiency
1
2021
334
0.140
Why?
Housing
1
2019
146
0.130
Why?
Echocardiography, Doppler
1
2018
115
0.130
Why?
Perioperative Care
1
2020
235
0.130
Why?
Odds Ratio
2
2020
1061
0.130
Why?
Cardiopulmonary Resuscitation
1
2020
334
0.130
Why?
Patient Transfer
1
2019
183
0.130
Why?
Infant, Very Low Birth Weight
1
2017
72
0.120
Why?
Continuity of Patient Care
1
2019
287
0.120
Why?
Premature Birth
1
2020
376
0.120
Why?
Heart Arrest
1
2020
401
0.120
Why?
Patient Readmission
2
2019
716
0.120
Why?
Echocardiography
1
2019
653
0.120
Why?
Disease Models, Animal
6
2011
4553
0.120
Why?
Infant, Extremely Premature
1
2017
67
0.120
Why?
Hemodynamics
6
2011
1126
0.120
Why?
Glucocorticoids
1
2000
544
0.120
Why?
Antimicrobial Stewardship
1
2018
128
0.120
Why?
Child
8
2023
22928
0.120
Why?
Risk Adjustment
1
2016
84
0.120
Why?
Vasoconstriction
2
2008
216
0.110
Why?
Clinical Nursing Research
1
2015
12
0.110
Why?
Ligation
3
2025
93
0.110
Why?
Liver Neoplasms
1
2002
768
0.110
Why?
Communication
1
2021
966
0.110
Why?
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
3
2011
28
0.110
Why?
Enterocolitis, Necrotizing
2
2024
41
0.100
Why?
Enzyme Activation
3
2005
790
0.100
Why?
Nitroarginine
5
2006
57
0.100
Why?
rho-Associated Kinases
3
2011
82
0.100
Why?
Pregnancy Complications, Cardiovascular
2
2004
84
0.100
Why?
Premedication
2
2024
43
0.100
Why?
Program Evaluation
1
2017
951
0.100
Why?
Vascular Endothelial Growth Factors
2
2002
79
0.100
Why?
Linear Models
2
2025
860
0.090
Why?
Heart Septal Defects, Ventricular
2
2026
48
0.090
Why?
Mothers
1
2019
781
0.090
Why?
Administration, Inhalation
2
2007
597
0.090
Why?
Isoenzymes
2
2011
299
0.090
Why?
Vasodilator Agents
2
2011
330
0.090
Why?
Pneumonia
1
2018
645
0.090
Why?
Apgar Score
2
2023
18
0.090
Why?
Enzyme Inhibitors
5
2009
839
0.080
Why?
Leadership
1
2015
402
0.080
Why?
Health Services Accessibility
1
2019
1084
0.080
Why?
Sulfones
3
2005
127
0.080
Why?
Infant, Low Birth Weight
2
2022
148
0.080
Why?
Pyridines
4
2011
604
0.080
Why?
Chronic Disease
2
2014
1844
0.080
Why?
Myocytes, Smooth Muscle
1
2011
261
0.080
Why?
Prevalence
3
2024
2849
0.080
Why?
Treatment Outcome
5
2025
11498
0.070
Why?
Magnetic Resonance Imaging
1
2022
3834
0.070
Why?
Serotonin
1
2011
290
0.070
Why?
Risk Factors
4
2025
10739
0.070
Why?
Pulmonary Wedge Pressure
2
2009
68
0.070
Why?
Amides
2
2006
100
0.070
Why?
Cohort Studies
4
2021
5895
0.070
Why?
Muscle, Smooth, Vascular
3
2009
450
0.070
Why?
Immunohistochemistry
2
2002
1740
0.070
Why?
Procollagen-Proline Dioxygenase
1
2007
27
0.060
Why?
Estradiol
2
2001
528
0.060
Why?
Immediate-Early Proteins
1
2007
48
0.060
Why?
Cardiovascular Agents
1
2008
158
0.060
Why?
Oxadiazoles
3
2011
36
0.060
Why?
Comorbidity
2
2024
1685
0.060
Why?
Case-Control Studies
2
2024
3644
0.060
Why?
Hospitals, Low-Volume
1
2026
24
0.060
Why?
Selenium
1
2025
49
0.060
Why?
Hydroxyeicosatetraenoic Acids
1
2005
36
0.060
Why?
Renal Replacement Therapy
1
2026
99
0.060
Why?
Protein Kinase Inhibitors
2
2008
983
0.050
Why?
Thoracoscopy
1
2024
62
0.050
Why?
Chylothorax
1
2024
20
0.050
Why?
Abnormalities, Multiple
1
2026
198
0.050
Why?
Antibiotic Prophylaxis
1
2025
129
0.050
Why?
Hyperoxia
1
2005
99
0.050
Why?
Pyrazoles
2
2005
509
0.050
Why?
Anastomosis, Surgical
1
2024
159
0.050
Why?
Birth Weight
1
2007
521
0.050
Why?
Continuous Positive Airway Pressure
1
2024
92
0.050
Why?
Body Weight
2
2005
1001
0.050
Why?
Noninvasive Ventilation
1
2024
64
0.050
Why?
Video Recording
1
2024
210
0.050
Why?
Intracellular Signaling Peptides and Proteins
1
2006
475
0.050
Why?
Parenteral Nutrition
1
2024
105
0.050
Why?
Chromones
1
2002
44
0.050
Why?
Homeodomain Proteins
1
2007
526
0.050
Why?
Platelet-Derived Growth Factor
1
2003
88
0.050
Why?
Receptors, Vascular Endothelial Growth Factor
1
2002
108
0.050
Why?
Acetaminophen
1
2025
268
0.050
Why?
Morpholines
1
2002
129
0.050
Why?
Clinical Trials as Topic
1
2007
1048
0.050
Why?
Oligonucleotides
1
2002
148
0.040
Why?
Airway Extubation
1
2022
60
0.040
Why?
Drug Administration Schedule
2
2001
777
0.040
Why?
Prostaglandins
1
2001
97
0.040
Why?
Estrogen Antagonists
1
2001
46
0.040
Why?
Gastroesophageal Reflux
1
2024
244
0.040
Why?
Artifacts
1
2022
135
0.040
Why?
Cardiac Catheterization
1
2025
552
0.040
Why?
Respiration
1
2022
210
0.040
Why?
Image Enhancement
1
2022
194
0.040
Why?
Soluble Guanylyl Cyclase
2
2011
15
0.040
Why?
Postoperative Period
1
2021
360
0.040
Why?
Phosphatidylinositol 3-Kinases
1
2002
374
0.040
Why?
Piperazines
3
2011
395
0.040
Why?
Dose-Response Relationship, Drug
3
2011
2061
0.040
Why?
Injections, Intra-Arterial
1
2000
26
0.040
Why?
Protoporphyrins
1
2000
16
0.040
Why?
Prognosis
2
2019
4207
0.040
Why?
Epinephrine
1
2020
155
0.040
Why?
Quinoxalines
2
2011
67
0.040
Why?
Perioperative Period
1
2020
70
0.040
Why?
Benzodiazepines
1
2021
163
0.040
Why?
Injections, Intramuscular
1
2000
143
0.040
Why?
Airway Management
1
2020
79
0.040
Why?
Proteus
1
2019
6
0.040
Why?
Enterobacter
1
2019
8
0.040
Why?
Pain Management
1
2023
405
0.040
Why?
DNA-Binding Proteins
1
2007
1526
0.040
Why?
Transportation of Patients
1
2020
67
0.040
Why?
Aftercare
1
2021
218
0.040
Why?
Colorado
2
2020
4704
0.040
Why?
Body Temperature Regulation
1
2020
105
0.040
Why?
Body Temperature
1
2020
225
0.040
Why?
Hypnotics and Sedatives
1
2021
218
0.040
Why?
Contrast Media
1
2022
484
0.040
Why?
RNA, Messenger
1
2007
2856
0.040
Why?
Benchmarking
1
2020
185
0.040
Why?
Reference Values
1
2000
814
0.040
Why?
Receptors, Estrogen
1
2001
426
0.040
Why?
Infectious Disease Transmission, Vertical
1
2020
186
0.040
Why?
Blood Vessels
1
2000
175
0.040
Why?
Ultrasonography, Prenatal
1
2020
295
0.030
Why?
Cesarean Section
1
2000
224
0.030
Why?
Surgical Mesh
1
2018
52
0.030
Why?
Operating Rooms
1
2020
148
0.030
Why?
Imaging, Three-Dimensional
1
2022
574
0.030
Why?
Sterilization
1
2017
24
0.030
Why?
Program Development
1
2020
372
0.030
Why?
Drug Utilization
1
2018
166
0.030
Why?
Congenital Abnormalities
1
2018
105
0.030
Why?
Gene Expression Regulation, Developmental
1
2002
897
0.030
Why?
Diagnosis, Differential
1
2002
1515
0.030
Why?
Hydrogen-Ion Concentration
1
2018
555
0.030
Why?
Risk Assessment
2
2018
3595
0.030
Why?
Acetylcholine
2
2009
204
0.030
Why?
Patient Care Team
1
2021
687
0.030
Why?
Regression Analysis
1
2018
1014
0.030
Why?
3',5'-Cyclic-GMP Phosphodiesterases
2
2005
18
0.030
Why?
Cyclic Nucleotide Phosphodiesterases, Type 5
2
2005
22
0.030
Why?
Staphylococcus aureus
1
2019
448
0.030
Why?
Sildenafil Citrate
2
2005
59
0.030
Why?
Burns
1
2020
365
0.030
Why?
Escherichia coli
1
2019
835
0.030
Why?
Prenatal Exposure Delayed Effects
1
2001
682
0.030
Why?
Purines
2
2005
185
0.030
Why?
Survival Analysis
1
2017
1333
0.030
Why?
Cells, Cultured
2
2011
4185
0.020
Why?
Analgesics, Opioid
1
2021
1144
0.020
Why?
Vaccination
1
2021
1489
0.020
Why?
Ketanserin
1
2011
12
0.020
Why?
Serotonin 5-HT2 Receptor Antagonists
1
2011
10
0.020
Why?
Hysterotomy
1
2011
9
0.020
Why?
Sertraline
1
2011
28
0.020
Why?
Receptors, Serotonin
1
2011
35
0.020
Why?
Prostaglandin-Endoperoxide Synthases
2
2001
74
0.020
Why?
Nitroprusside
1
2011
72
0.020
Why?
Fluoxetine
1
2011
56
0.020
Why?
Hypertrophy, Right Ventricular
2
2003
147
0.020
Why?
Kidney
1
2018
1507
0.020
Why?
Adrenal Cortex Hormones
1
2013
507
0.020
Why?
Hydrogen Peroxide
1
2011
339
0.020
Why?
Prospective Studies
1
2021
7956
0.020
Why?
Constriction
1
2008
47
0.020
Why?
Indoles
1
2011
487
0.020
Why?
Signal Transduction
3
2006
5242
0.020
Why?
Child, Preschool
1
2022
11876
0.020
Why?
Regional Blood Flow
1
2008
506
0.020
Why?
Phosphoric Diester Hydrolases
1
2004
50
0.010
Why?
Organ Size
1
2005
481
0.010
Why?
Heart Atria
1
2004
146
0.010
Why?
Drug Combinations
1
2005
386
0.010
Why?
Neovascularization, Physiologic
1
2005
193
0.010
Why?
Blood Flow Velocity
1
2004
415
0.010
Why?
Receptor, Platelet-Derived Growth Factor beta
1
2003
31
0.010
Why?
Receptor, Platelet-Derived Growth Factor alpha
1
2003
55
0.010
Why?
Meclofenamic Acid
1
2001
9
0.010
Why?
8-Bromo Cyclic Adenosine Monophosphate
1
2001
21
0.010
Why?
Aorta
1
2004
433
0.010
Why?
Cyclooxygenase 1
1
2001
26
0.010
Why?
Infusions, Intra-Arterial
1
2001
62
0.010
Why?
Cyclooxygenase Inhibitors
1
2001
81
0.010
Why?
Intramolecular Oxidoreductases
1
2001
66
0.010
Why?
Pulmonary Ventilation
1
2001
83
0.010
Why?
Cyclooxygenase 2
1
2001
175
0.010
Why?
Organ Specificity
1
2001
312
0.010
Why?
Ligands
1
2003
672
0.010
Why?
Cytochrome P-450 Enzyme System
1
2001
161
0.010
Why?
Drug Interactions
1
2001
407
0.010
Why?
Physical Stimulation
1
2000
68
0.010
Why?
Rats, Sprague-Dawley
1
2005
2531
0.010
Why?
Stress, Mechanical
1
2001
502
0.010
Why?
Muscle, Smooth
1
2000
151
0.010
Why?
Blotting, Western
1
2001
1223
0.010
Why?
Gene Expression
1
2003
1505
0.010
Why?
Rats
1
2005
5615
0.010
Why?
Grover's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)